Teng H-C, Huang M-J, Tang K-S, Yang S-S, Tseng C-S, Huang C-S
College of Medicine and Health, Fooyin University, 151 Chin-Hsueh Road, La-Tiao Hsiang, Kaohsiung Hsien 831, Taiwan.
Clin Genet. 2007 Oct;72(4):321-8. doi: 10.1111/j.1399-0004.2007.00873.x.
Gilbert's syndrome (GS) is caused by a reduction in the activity of hepatic bilirubin UDP-glucuronosyltransferase (UGT). This reduction is associated with UGT1A128 and UGT1A16 polymorphisms. Recent research also showed that carriage of UGT1A16 allele were significantly related with UGT1A73. Polymerase chain reaction-restriction fragment length polymorphism were utilized to determine UGT1A7 and UGT1A1 genes for 207 patients with GS and 207 gender/age-matched healthy controls. For the 207 healthy controls, linkage disequilibrium was observed between -57UGT1A7 and 622UGT1A7 loci (D' = 1.00 and r(2) = 1.00), -57UGT1A7 and 211UGT1A1 loci (D' = 0.72 and r(2) = 0.36), respectively. A dose-response effect for number of at-risk allele of UGT1A1 and risk for GS was noted (odds ratio (OR) = 8.19 for heterozygous UGT1A128 genotype; OR = 124.96 for homozygous UGT1A128 genotype; and p for trend <0.05). Patients with combined genotypes carrying UGT1A7 variant alleles and UGT1A1 variant alleles (including UGT1A128 and UGT1A1*6) are associated with increased risk of GS (OR = 13.96 for patients with combined genotype carrying at least one variant allele of UGT1A1 and UGT1A7). In conclusion, the -57UGT1A7 (T>G) is highly associated with UGT1A73 and moderately associated with 211UGT1A1 (G>A). Certain UGT1A1/UGT1A7 combined genotypes are risk factors of GS.
吉尔伯特综合征(GS)是由肝脏胆红素UDP-葡萄糖醛酸基转移酶(UGT)活性降低引起的。这种降低与UGT1A128和UGT1A16多态性有关。最近的研究还表明,UGT1A16等位基因的携带与UGT1A73显著相关。采用聚合酶链反应-限制性片段长度多态性方法,对207例GS患者和207例性别/年龄匹配的健康对照者的UGT1A7和UGT1A1基因进行检测。对于207例健康对照者,分别在-57UGT1A7和622UGT1A7位点(D' = 1.00,r(2) = 1.00)、-57UGT1A7和211UGT1A1位点(D' = 0.72,r(2) = 0.36)观察到连锁不平衡。注意到UGT1A1风险等位基因数量与GS风险之间存在剂量反应效应(杂合子UGT1A128基因型的优势比(OR) = 8.19;纯合子UGT1A128基因型的OR = 124.96;趋势p <0.05)。携带UGT1A7变异等位基因和UGT1A1变异等位基因(包括UGT1A128和UGT1A1*6)的联合基因型患者与GS风险增加相关(携带至少一个UGT1A1和UGT1A7变异等位基因的联合基因型患者的OR = 13.96)。总之,-57UGT1A7(T>G)与UGT1A73高度相关,与211UGT1A1(G>A)中度相关。某些UGT1A1/UGT1A7联合基因型是GS的危险因素。